Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    

MEDIVATION INC
Mes dernières consult.
Most popular
SummaryNewsCompany 
News SummaryMost relevantAll newsSector newsTweets

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2013 | 10:34pm CEST

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIVATION INC
2016 Drugmaker Sanofi hungry for deals after earnings beat
2016 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016 FARUQI & FARUQI, LLP : Announces Filing of a Class Action Lawsuit Against Mediva..
2016 EXCLUSIVE - GW PHARMACEUTICALS HIRES : sources
2016 MEDIVATION SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation..
2016 Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation,..
2016 Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale o..
2016 SHAREHOLDER UPDATE : Brodsky & Smith, LLC Announces an Investigation of The Boar..
2016 Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale o..
More news
News from SeekingAlpha
05/17 Vantage Point - Are Charities The Best Way To Pay For Costly Drugs?
04/10 Axovant Sciences announces appointment of Dr. David Hung as CEO and expansion..
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
02/10 BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De..
02/03 Pfizer May Be Another IBM
Managers
NameTitle
David T. Hung President, Chief Executive Officer & Director
Kim D. Blickenstaff Chairman
Mohammad Hirmand Chief Medical Officer
Anne Bowdidge Senior Director-Investor Relations
Sandy Cooper Senior Vice President-Human Resources
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0
GILEAD SCIENCES11.73%106 054
REGENERON PHARMACEUTICALS19.69%46 395
VERTEX PHARMACEUTICALS110.07%38 985
ACTELION23.81%29 840
GENMAB14.75%12 865